Intravascular Large B-Cell Lymphoma
6 clinical trials · Condition
◉ Watch Intravascular Large B-Cell Lymphoma
| Record | Firm | Date |
|---|---|---|
| Testing CC-486 (Oral Azacitidine) Plus the Standard Drug Therapy in Patients 75 Years or Older With Newly Diagnosed Diffuse Large B Cell Lymphoma (NCT04799275) | National Cancer Institute (NCI) | 2021-05-20 |
| Zanubrutinib Combined With R-CHOP in Newly-diagnosed Intravascular Large B-cell Lymphoma (NCT04899570) | Peking Union Medical College Hospital | 2021-04-01 |
| Nivolumab With or Without Varlilumab in Treating Patients With Relapsed or Refractory Aggressive B-cell Lymphomas (NCT03038672) | National Cancer Institute (NCI) | 2018-12-21 |
| Nivolumab and Combination Chemotherapy in Treating Participants With Diffuse Large B-Cell Lymphoma (NCT03704714) | Northwestern University | 2018-11-20 |
Track Intravascular Large B-Cell Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.